A method for making infectious, propagation defective tr339...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 31/70 (2006.01) C07H 21/02 (2006.01) C07K 14/18 (2006.01) C12N 5/10 (2006.01) C12N 7/01 (2006.01) C12N 15/86 (2006.01)

Patent

CA 2281858

The present invention provides a method of delivering immunogenic or therapeutic proteins to bone marrow cells using alphavirus vectors. The alphavirus vectors disclosed herein target specifically to bone marrow tissue, and viral genomes persist in bone marrow for at least three months post- infection. No or very low levels of virus were detected in quadricep, brain, and sera of treated animals. The sequence of a consensus Sindbis cDNA clone, pTR339, and infectious RNA transcripts, infectious virus particles, and pharmaceutical formulations derived therefrom are also disclosed. The sequence of the genomic RNA of the Girdwood S.A. virus, and cDNA clones, infectious RNA transcripts, infectious virus particles, and pharmaceutical formulations derived therefrom are also disclosed.

La présente invention se rapporte à un procédé permettant l'apport de protéines immunogéniques ou thérapeutiques à des cellules de moelle osseuse au moyen de vecteurs d'alphavirus. Les vecteurs d'alphavirus de cette invention ciblent spécifiquement le tissu de moelle osseuse, et les génomes viraux persistent dans la moelle osseuse pendant au moins trois mois après l'infection. On a décelé des concentrations de virus très faibles ou nulles dans les quadriceps, le cerveau et le sérum des animaux traités. L'invention se rapporte notamment à la séquence d'un clone consensus d'ADNc du virus Sindbis, pTR339, ainsi qu'à des produits de transcription d'ARN infectieux, des particules de virus infectieux et des formulations pharmaceutiques dérivés à partir d'une telle séquence. L'invention se rapporte également à la séquence de l'ARN génomique du virus Girdwood S.A, ainsi qu'à des clones d'ADNc, des produits de transcription d'ARN infectieux, des particules de virus infectieux et des formulations pharmaceutiques dérivés à partir d'une telle séquence.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A method for making infectious, propagation defective tr339... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A method for making infectious, propagation defective tr339..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A method for making infectious, propagation defective tr339... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1426177

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.